{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T20:37:44Z","timestamp":1792787864165,"version":"4.5.0"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T00:00:00Z","timestamp":1789689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T00:00:00Z","timestamp":1789948800000},"content-version":"vor","delay-in-days":3,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Ruhr-Universit\u00e4t Bochum","id":[{"id":"https:\/\/ror.org\/04tsk2644","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background\/Objectives<\/jats:title>\n                    <jats:p>Patients hospitalized with acute decompensated heart failure (ADHF) represent a clinically vulnerable population. However, the impact of concomitant severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection and the prognostic relevance of viral burden in this setting remain incompletely understood.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We conducted a retrospective cohort study including 2,002 adults hospitalized with ADHF at a tertiary academic center between March 2020 and December 2024. SARS-CoV-2 infection was confirmed by reverse transcription quantitative polymerase chain reaction (RT-qPCR) during the index hospitalization. The primary outcome was in-hospital mortality. Secondary clinical outcomes were ICU admission and invasive mechanical ventilation, while hospital and ICU length of stay were assessed as resource-utilization outcomes. Multivariable regression models adjusted for clinically relevant covariates were used to assess associations between infection status and outcomes. Among infected patients, cycle threshold (Ct) values were analyzed as surrogate markers of viral burden.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Of the 2,002 patients included, 246 (12.3%) had confirmed SARS-CoV-2 infection. Compared with uninfected patients, infected individuals had higher in-hospital mortality (32.5% vs. 20.6%), ICU admission (61.4% vs. 50.7%), and invasive mechanical ventilation (6.5% vs. 2.4%) (all\n                      <jats:italic>p<\/jats:italic>\n                      \u2009\u2264\u20090.002). After multivariable adjustment, SARS-CoV-2 infection remained associated with in-hospital mortality (aOR 2.63,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.0002), ICU admission (aOR 1.79,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.0027), and invasive mechanical ventilation (aOR 2.84,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.0017). Infection was also associated with longer hospital stay (a\u03b2\u2009+\u20099.23 days,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.0001) and longer ICU stay (a\u03b2\u2009+\u20097.85 days,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.0017). Among infected patients, lower median Ct values were associated with higher in-hospital mortality (aOR 0.89 per Ct unit,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.0338), while lower minimum Ct values were associated with longer hospital stay (adjusted \u03b2\u2009\u2212\u20090.44 days per Ct unit,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.0359).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Among patients hospitalized with ADHF, concomitant SARS-CoV-2 infection was associated with substantially worse in-hospital outcomes and greater healthcare resource utilization. The observed associations between lower Ct values and adverse in-hospital outcomes should be considered hypothesis-generating and require prospective validation because Ct values are imperfect surrogate markers of viral burden.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12879-026-14407-y","type":"journal-article","created":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T15:45:30Z","timestamp":1789746330000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Impact of SARS-CoV-2 infection and viral burden on outcomes in acute decompensated heart failure"],"prefix":"10.1186","volume":"26","author":[{"given":"Mohamad Amer","family":"Nashtar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haris","family":"Sehovic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammed","family":"Salemdawod","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gizem","family":"Garipoglu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bet\u00fcl","family":"\u00d6demis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asterios","family":"Tzalavras","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Steinmetz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali","family":"Canbay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mustafa","family":"\u00d6z\u00e7\u00fcr\u00fcmez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Varnavas","family":"Varnavas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Polykarpos Christos","family":"Patsalis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5179-0327","authenticated-orcid":false,"given":"Antonios","family":"Katsounas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,18]]},"reference":[{"issue":"17","key":"14407_CR1","doi-asserted-by":"publisher","first-page":"3272","DOI":"10.1093\/cvr\/cvac013","volume":"118","author":"G Savarese","year":"2023","unstructured":"Savarese G, Becher PM, Lund LH, Seferovic P, Rosano GMC, Coats AJS. Global burden of heart failure: a comprehensive and updated review of epidemiology. Cardiovasc Res. 2023;118(17):3272\u201387.","journal-title":"Cardiovasc Res"},{"issue":"18","key":"14407_CR2","first-page":"e895","volume":"145","author":"PA Heidenreich","year":"2022","unstructured":"Heidenreich PA, Bozkurt B, Aguilar D, Allen LA, Byun JJ, Colvin MM, et al. 2022 AHA\/ACC\/HFSA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation. 2022;145(18):e895\u20131032.","journal-title":"Circulation"},{"issue":"6","key":"14407_CR3","doi-asserted-by":"publisher","first-page":"1197","DOI":"10.1016\/j.mcna.2025.03.001","volume":"109","author":"MM Kittleson","year":"2025","unstructured":"Kittleson MM, Raj LM, Smith DT. In-Hospital Management of Acute Heart Failure. Med Clin North Am. 2025;109(6):1197\u2013217.","journal-title":"Med Clin North Am"},{"issue":"36","key":"14407_CR4","doi-asserted-by":"publisher","first-page":"3599","DOI":"10.1093\/eurheartj\/ehab368","volume":"42","author":"TA McDonagh","year":"2021","unstructured":"McDonagh TA, Metra M, Adamo M, Gardner RS, Baumbach A, B\u00f6hm M, et al. 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure. Eur Heart J. 2021;42(36):3599\u2013726.","journal-title":"Eur Heart J"},{"key":"14407_CR5","doi-asserted-by":"crossref","unstructured":"Damluji, A.A., D.E. Forman, S. Van Diepen, K.P. Alexander, R.L. Page, S.L. Hummel, et al., Older Adults in the Cardiac Intensive Care Unit: Factoring Geriatric Syndromes in the Management, Prognosis, and Process of Care: A Scientific Statement From the American Heart Association. Circulation, 2020. 141(2): e6\u201332.","DOI":"10.1161\/CIR.0000000000000741"},{"issue":"10106","key":"14407_CR6","doi-asserted-by":"publisher","first-page":"1981","DOI":"10.1016\/S0140-6736(17)31071-1","volume":"390","author":"M Metra","year":"2017","unstructured":"Metra M, Teerlink JR. Heart failure. Lancet. 2017;390(10106):1981\u201395.","journal-title":"Lancet"},{"issue":"20","key":"14407_CR7","doi-asserted-by":"publisher","first-page":"1648","DOI":"10.1161\/CIRCULATIONAHA.120.046941","volume":"141","author":"KJ Clerkin","year":"2020","unstructured":"Clerkin KJ, Fried JA, Raikhelkar J, Sayer G, Griffin JM, Masoumi A, et al. COVID-19 and Cardiovascular Disease. Circulation. 2020;141(20):1648\u201355.","journal-title":"Circulation"},{"issue":"6","key":"14407_CR8","doi-asserted-by":"publisher","first-page":"2071","DOI":"10.14336\/AD.2023.0314","volume":"14","author":"H Shu","year":"2023","unstructured":"Shu H, Wen Z, Li N, Zhang Z, Ceesay BM, Peng Y, et al. COVID-19 and Cardiovascular Diseases: From Cellular Mechanisms to Clinical Manifestations. Aging Dis. 2023;14(6):2071\u201388.","journal-title":"Aging Dis"},{"issue":"9","key":"14407_CR9","doi-asserted-by":"publisher","first-page":"e008354","DOI":"10.1161\/CIRCHEARTFAILURE.121.008354","volume":"14","author":"P Goyal","year":"2021","unstructured":"Goyal P, Reshetnyak E, Khan S, Musse M, Navi BB, Kim J, et al. Clinical Characteristics and Outcomes of Adults With a History of Heart Failure Hospitalized for COVID-19. Circ Heart Fail. 2021;14(9):e008354.","journal-title":"Circ Heart Fail"},{"key":"14407_CR10","doi-asserted-by":"crossref","unstructured":"Berg DD, Divakaran S, Hedayati M, et al. Clinical presentation, disease course, and outcome of COVID-19 in hospitalized patients with and without pre-existing cardiac disease: a cohort study across 18 countries. Eur Heart J. 2022;43(11):1104-1120.","DOI":"10.1093\/eurheartj\/ehab656"},{"issue":"12","key":"14407_CR11","doi-asserted-by":"publisher","first-page":"2205","DOI":"10.1002\/ejhf.1990","volume":"22","author":"JR Rey","year":"2020","unstructured":"Rey JR, Caro-Cod\u00f3n J, Rosillo SO, Iniesta M, Castrej\u00f3n-Castrej\u00f3n \u00c1S, Marco-Clement I, et al. Heart failure in COVID-19 patients: prevalence, incidence and prognostic implications. Eur J Heart Fail. 2020;22(12):2205\u201315.","journal-title":"Eur J Heart Fail"},{"issue":"10","key":"14407_CR12","doi-asserted-by":"publisher","first-page":"1290","DOI":"10.1161\/CIRCRESAHA.123.321876","volume":"132","author":"EJ Tsai","year":"2023","unstructured":"Tsai EJ, C\u02c7ih\u00e1kov\u00e1 D, Tucker NR. Cell-Specific Mechanisms in the Heart of COVID-19 Patients. Circ Res. 2023;132(10):1290\u2013301.","journal-title":"Circ Res"},{"issue":"10","key":"14407_CR13","doi-asserted-by":"publisher","first-page":"1666","DOI":"10.1093\/cvr\/cvaa106","volume":"116","author":"TJ Guzik","year":"2020","unstructured":"Guzik TJ, Mohiddin SA, Dimarco A, Patel V, Savvatis K, Marelli-Berg FM, et al. COVID-19 and the cardiovascular system: implications for risk assessment, diagnosis, and treatment options. Cardiovasc Res. 2020;116(10):1666\u201387.","journal-title":"Cardiovasc Res"},{"issue":"10332","key":"14407_CR14","doi-asserted-by":"publisher","first-page":"1303","DOI":"10.1016\/S0140-6736(22)00462-7","volume":"399","author":"T Nyberg","year":"2022","unstructured":"Nyberg T, Ferguson NM, Nash SG, Webster HH, Flaxman S, Andrews N, et al. Comparative analysis of the risks of hospitalisation and death associated with SARS-CoV-2 omicron (B.1.1.529) and delta (B.1.617.2) variants in England: a cohort study. Lancet. 2022;399(10332):1303\u201312.","journal-title":"Lancet"},{"issue":"3","key":"14407_CR15","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1093\/infdis\/jiac411","volume":"227","author":"FP Esper","year":"2023","unstructured":"Esper FP, Adhikari TM, Tu ZJ, Cheng YW, El-Haddad K, Farkas DH, et al. Alpha to Omicron: Disease Severity and Clinical Outcomes of Major SARS-CoV-2 Variants. J Infect Dis. 2023;227(3):344\u201352.","journal-title":"J Infect Dis"},{"issue":"3","key":"14407_CR16","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1007\/s40121-020-00324-3","volume":"9","author":"SN Rao","year":"2020","unstructured":"Rao SN, Manissero D, Steele VR, Pareja J. A Systematic Review of the Clinical Utility of Cycle Threshold Values in the Context of COVID-19. Infect Dis Ther. 2020;9(3):573\u201386.","journal-title":"Infect Dis Ther"},{"issue":"11","key":"14407_CR17","doi-asserted-by":"publisher","first-page":"e0277653","DOI":"10.1371\/journal.pone.0277653","volume":"17","author":"C Follonier","year":"2022","unstructured":"Follonier C, Tessitore E, Handgraaf S, Carballo D, Achard M, Pech\u00e8re-Bertschi A, et al. Cardiovascular therapy use, modification, and in-hospital death in patients with COVID-19: A cohort study. PLoS ONE. 2022;17(11):e0277653.","journal-title":"PLoS ONE"},{"issue":"15","key":"14407_CR18","doi-asserted-by":"publisher","first-page":"1444","DOI":"10.1016\/j.jacc.2023.12.024","volume":"83","author":"TM Maddox","year":"2024","unstructured":"Maddox TM, Januzzi JL, Allen LA, Breathett K, Brouse S, Butler J, et al. 2024 ACC Expert Consensus Decision Pathway for Treatment of Heart Failure With Reduced Ejection Fraction. J Am Coll Cardiol. 2024;83(15):1444\u201388.","journal-title":"J Am Coll Cardiol"},{"issue":"3","key":"14407_CR19","first-page":"315","volume":"108","author":"B Ford","year":"2023","unstructured":"Ford B, Dore M, Bartlett B. Management of Heart Failure: Updated Guidelines From the AHA\/ACC. Am Fam Physician. 2023;108(3):315\u201320.","journal-title":"Am Fam Physician"},{"issue":"6","key":"14407_CR20","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1016\/j.jacc.2022.11.042","volume":"81","author":"GA Mensah","year":"2023","unstructured":"Mensah GA, Vaduganathan M, Roth GA. Acute Cardiovascular Complications of COVID-19. J Am Coll Cardiol. 2023;81(6):570\u20133.","journal-title":"J Am Coll Cardiol"},{"issue":"11","key":"14407_CR21","doi-asserted-by":"publisher","first-page":"1068","DOI":"10.1177\/08850666231182380","volume":"38","author":"A Hashem","year":"2023","unstructured":"Hashem A, Khalouf A, Mohamed MS, Nayfeh T, Elkhapery A, Elbahnasawy M, et al. COVID-19 Infection Is Associated With Increased In-Hospital Mortality and Complications in Patients With Acute Heart Failure: Insight From National Inpatient Sample (2020). J Intensive Care Med. 2023;38(11):1068\u201377.","journal-title":"J Intensive Care Med"},{"issue":"4","key":"14407_CR22","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1038\/s41401-022-00998-0","volume":"44","author":"S-w Xu","year":"2023","unstructured":"Xu S-w, Ilyas I, Weng J-p. Endothelial dysfunction in COVID-19: an overview of evidence, biomarkers, mechanisms and potential therapies. Acta Pharmacol Sin. 2023;44(4):695\u2013709.","journal-title":"Acta Pharmacol Sin"},{"issue":"1","key":"14407_CR23","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.cardfail.2021.08.013","volume":"28","author":"AS Bhatt","year":"2022","unstructured":"Bhatt AS, Adler ED, Albert NM, Anyanwu A, Bhadelia N, Cooper LT, et al. Coronavirus Disease-2019 and Heart Failure: A Scientific Statement From the Heart Failure Society of America. J Card Fail. 2022;28(1):93\u2013112.","journal-title":"J Card Fail"},{"issue":"2","key":"14407_CR24","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1007\/s10741-020-10037-x","volume":"26","author":"EA Adeghate","year":"2021","unstructured":"Adeghate EA, Eid N, Singh J. Mechanisms of COVID-19-induced heart failure: a short review. Heart Fail Rev. 2021;26(2):363\u20139.","journal-title":"Heart Fail Rev"},{"issue":"20","key":"14407_CR25","doi-asserted-by":"publisher","first-page":"2334","DOI":"10.1016\/j.jacc.2020.09.549","volume":"76","author":"J Alvarez-Garcia","year":"2020","unstructured":"Alvarez-Garcia J, Lee S, Gupta A, Cagliostro M, Joshi AA, Rivas-Lasarte M, et al. Prognostic Impact of Prior Heart Failure in Patients Hospitalized With COVID-19. J Am Coll Cardiol. 2020;76(20):2334\u201348.","journal-title":"J Am Coll Cardiol"},{"issue":"1","key":"14407_CR26","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.jchf.2020.11.003","volume":"9","author":"AS Bhatt","year":"2021","unstructured":"Bhatt AS, Jering KS, Vaduganathan M, Claggett BL, Cunningham JW, Rosenthal N, et al. Clinical Outcomes in Patients With Heart Failure Hospitalized With COVID-19. JACC Heart Fail. 2021;9(1):65\u201373.","journal-title":"JACC Heart Fail"},{"issue":"1","key":"14407_CR27","doi-asserted-by":"publisher","first-page":"947","DOI":"10.1186\/s12879-022-07935-w","volume":"22","author":"C Hu","year":"2022","unstructured":"Hu C, Liu YK, Sun QD, Du Z, Fang YQ, Guo F, et al. Clinical characteristics and risk factors for a prolonged length of stay of patients with asymptomatic and mild COVID-19 during the wave of Omicron from Shanghai, China. BMC Infect Dis. 2022;22(1):947.","journal-title":"BMC Infect Dis"},{"issue":"11","key":"14407_CR28","doi-asserted-by":"publisher","first-page":"300060522113744","DOI":"10.1177\/03000605221137443","volume":"50","author":"L Dogan","year":"2022","unstructured":"Dogan L, Allahverdiyeva A, \u00d6nel M, Me\u015fe S, Saka Ersin E, Anakl\u0131 \u0130, et al. Is SARS-CoV-2 viral load a predictor of mortality in COVID-19 acute respiratory distress syndrome patients? J Int Med Res. 2022;50(11):3000605221137443.","journal-title":"J Int Med Res"},{"issue":"36","key":"14407_CR29","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.15585\/mmwr.mm7136a3","volume":"71","author":"M Tassetto","year":"2022","unstructured":"Tassetto M, Garcia-Knight M, Anglin K, Lu S, Zhang A, Romero M, et al. Detection of Higher Cycle Threshold Values in Culturable SARS-CoV-2 Omicron BA.1 Sublineage Compared with Pre-Omicron Variant Specimens - San Francisco Bay Area, California, July 2021-March 2022. MMWR Morb Mortal Wkly Rep. 2022;71(36):1151\u20134.","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"11","key":"14407_CR30","doi-asserted-by":"publisher","first-page":"e761","DOI":"10.1093\/cid\/ciaa1469","volume":"72","author":"PP Salvatore","year":"2021","unstructured":"Salvatore PP, Dawson P, Wadhwa A, Rabold EM, Buono S, Dietrich EA, et al. Epidemiological Correlates of Polymerase Chain Reaction Cycle Threshold Values in the Detection of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2). Clin Infect Dis. 2021;72(11):e761\u20137.","journal-title":"Clin Infect Dis"},{"key":"14407_CR31","doi-asserted-by":"publisher","first-page":"100855","DOI":"10.1016\/j.lanepe.2024.100855","volume":"38","author":"P Hedberg","year":"2024","unstructured":"Hedberg P, Parczewski M, Serwin K, Marchetti G, Bai F, Ole Jensen B-E, et al. In-hospital mortality during the wild-type, alpha, delta, and omicron SARS-CoV-2 waves: a multinational cohort study in the EuCARE project. Lancet Reg Health - Europe. 2024;38:100855.","journal-title":"Lancet Reg Health - Europe"},{"key":"14407_CR32","doi-asserted-by":"publisher","unstructured":"Karuniawati A, Pasaribu AP, Lazarus G, Irawany V, Nusantara DU, Sinto R, et al. Characteristics and clinical outcomes of patients with pre-delta, delta and omicron SARS-CoV-2 infection in Indonesia (2020-2023): a multicentre prospective cohort study. Lancet Reg Health Southeast Asia. 2024;22:100348. https:\/\/doi.org\/10.1016\/j.lansea.2024.100348.","DOI":"10.1016\/j.lansea.2024.100348"},{"issue":"1","key":"14407_CR33","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1093\/infdis\/jiac332","volume":"227","author":"M Manali","year":"2022","unstructured":"Manali M, Bissett LA, Amat JAR, Logan N, Scott S, Hughes EC, et al. SARS-CoV-2 Evolution and Patient Immunological History Shape the Breadth and Potency of Antibody-Mediated Immunity. J Infect Dis. 2022;227(1):40\u20139.","journal-title":"J Infect Dis"},{"issue":"22","key":"14407_CR34","doi-asserted-by":"publisher","first-page":"2131","DOI":"10.1016\/j.jacc.2023.03.426","volume":"81","author":"M Pagnesi","year":"2023","unstructured":"Pagnesi M, Metra M, Cohen-Solal A, Edwards C, Adamo M, Tomasoni D, et al. Uptitrating Treatment After Heart Failure Hospitalization Across the Spectrum of Left Ventricular Ejection Fraction. J Am Coll Cardiol. 2023;81(22):2131\u201344.","journal-title":"J Am Coll Cardiol"},{"issue":"8","key":"14407_CR35","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1016\/j.jchf.2020.05.006","volume":"8","author":"EM DeFilippis","year":"2020","unstructured":"DeFilippis EM, Reza N, Donald E, Givertz MM, Lindenfeld J, Jessup M. Considerations for Heart Failure Care During the COVID-19 Pandemic. JACC Heart Fail. 2020;8(8):681\u201391.","journal-title":"JACC Heart Fail"},{"key":"14407_CR36","first-page":"100440","volume":"45","author":"PK Srivastava","year":"2024","unstructured":"Srivastava PK, Klomhaus AM, Rafique A, Desai PS, Daniels LB, Yancy CW, et al. Guideline-directed medical therapy prescribing patterns and in-hospital outcomes among heart failure patients during COVID-19. Am Heart J Plus: Cardiol Res Pract. 2024;45:100440.","journal-title":"Am Heart J Plus: Cardiol Res Pract"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12879-026-14407-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-026-14407-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-026-14407-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T16:21:16Z","timestamp":1790007676000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12879-026-14407-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,18]]},"references-count":36,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["14407"],"URL":"https:\/\/doi.org\/10.1186\/s12879-026-14407-y","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,18]]},"assertion":[{"value":"29 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 September 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 September 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study has been performed in accordance with the ethical principles and standards of the 1964Helsinki declaration and the guidelines of the International Conference for Harmonization for Good Clinical Practice. The study was approved by the local institutional review board (IRB: \u201cEthik-Kommission der \u00c4rztekammer Westfalen-Lippe\u201d; Reference number: 2026\u2013293-f-N) on April 1, 2026. As anonymized data do not allow the identification of individuals under Article 4(1) and Recital 26 of the EU General Data Protection Regulation (GDPR), they are not subject to personal data protection requirements under the GDPR or the German Bundesdatenschutzgesetz(BDSG). Consequently, no separate informed consent is required for such use in research. This interpretation is consistent with the ethical review standards of the local ethics committee \u201cEthik-Kommission der \u00c4rztekammer Westfalen-Lippe\u201d.","order":1,"name":"Ethics","label":"Ethics approval and informed consent statement","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"1694"}}